EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Delta lactate-to-albumin ratio predicts major complications in patients with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy ​

Delta lactate-to-albumin ratio sagt große Komplikationen bei Patient:innen nach zytoreduktiver Chirurgie und hyperthermer intraperitonealer Chemotherapie voraus

AYTAÇ POLAT, SELCUK GULMEZ, DENİZ AVAN, AZİZ SERKAN SENGER, ORHAN UZUN, MURSİT DİNCER, NURİ HAVAN, ERDAL POLAT, MUSTAFA DUMAN

Turkish Journal of Medical Sciences · 15.10.2026 · 56 (5) · 1556-1564

DOI: 10.55730/1300-0144.6401 ↗

Auf einen Blick

Eine retrospektive Kohortenstudie bei 150 Erwachsenen zeigte: ΔLAR war mit großen postoperativen Komplikationen nach CRS/HIPEC assoziiert. Ein Cutoff von 1,65 hatte eine gute Vorhersageleistung.

Fragestellung

Kann das delta lactate-to-albumin ratio (ΔLAR) große postoperative Komplikationen nach CRS/HIPEC vorhersagen?

Methode

Retrospektive Kohortenstudie mit 150 Erwachsenen nach CRS/HIPEC. ΔLAR wurde aus Δ-Laktat und Serumalbumin berechnet; ROC-Analyse und multivariate logistische Regression.

Ergebnisse

Große Komplikationen traten bei 40 Patient:innen (26,7 %) auf. Cutoff 1,65: AUC 0,831, Sensitivität 70,0 %, Spezifität 85,5 %. Bei ΔLAR ≥1,65: 63,6 % vs. 11,3 %.

Einschränkungen

Larger prospective multicenter studies are needed to confirm these findings and establish their clinical applicability.

Schlussfolgerung der Autor:innen

ΔLAR ist ein einfacher, verfügbarer und robuster Composite-Marker mit Potenzial zur Vorhersage großer postoperativer Komplikationen nach CRS/HIPEC. Ein Cutoff von ≥1,65 könnte Hochrisikopatient:innen früh identifizieren.

Kernaussagen

  • ΔLAR sagte große Komplikationen nach CRS/HIPEC voraus
  • Cutoff 1,65: AUC 0,831; Sensitivität 70,0 %; Spezifität 85,5 %
  • ΔLAR blieb in der multivariaten Analyse ein unabhängiger Prädiktor

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 15.10.2026. Verfasst von AYTAÇ POLAT und 8 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

Auf einen BlickAbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/aim: Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) imposes substantial physiological stress and carries a high risk of major postoperative complications. This study aimed to evaluate the predictive value of the delta lactate-to-albumin ratio (ΔLAR) for major complications following CRS/HIPEC. Materials and methods: This retrospective cohort study evaluated 150 consecutive adult patients undergoing CRS/HIPEC. Δ-Lactate was calculated as the difference between arterial lactate levels measured before general anesthesia induction and at the end of surgery. ΔLAR was calculated by dividing Δ-lactate by serum albumin measured at 6–9 h postoperatively. Major postoperative complications were defined as Clavien–Dindo grade ≥III complications within 30 days. Receiver operating characteristic (ROC) curve analysis and multivariate logistic regression were performed to evaluate the predictive performance of ΔLAR.

Results

Major postoperative complications occurred in 40 patients (26.7%). Operative duration and Peritoneal Cancer Index scores were significantly higher in patients with major complications. Δ-Lactate, postoperative albumin, and ΔLAR showed significant intergroup differences. A ΔLAR cutoff of 1.65 demonstrated an area under the ROC curve of 0.831, with 70.0% sensitivity and 85.5% specificity. Patients with ΔLAR of ≥1.65 had a markedly higher incidence of major complications (63.6% vs. 11.3%) and longer hospital stays. In multivariate analysis, ΔLAR remained an independent predictor of major postoperative complications.

Conclusion

ΔLAR is a simple, readily available, and robust composite marker with potential for predicting major postoperative complications after CRS/HIPEC. A cutoff value of ≥1.65 may allow clinicians to identify high-risk patients early in the postoperative course, supporting more targeted monitoring and timely intervention. Larger prospective multicenter studies are needed to confirm these findings and establish their clinical applicability.

Zitieren

APA

POLAT, A., GULMEZ, S., AVAN, D., SENGER, A. S., UZUN, O., DİNCER, M., HAVAN, N., POLAT, E., & DUMAN, M. (2026). Delta lactate-to-albumin ratio predicts major complications in patients with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy ​. Turkish Journal of Medical Sciences, 56(5), 1556-1564. https://doi.org/10.55730/1300-0144.6401

Vancouver

POLAT A, GULMEZ S, AVAN D, SENGER AS, UZUN O, DİNCER M, et al. Delta lactate-to-albumin ratio predicts major complications in patients with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy ​. Turkish Journal of Medical Sciences. 2026;56(5):1556-1564. doi:10.55730/1300-0144.6401

BibTeX
@article{POLAT2026,
  author = {POLAT, AYTAÇ and GULMEZ, SELCUK and AVAN, DENİZ and SENGER, AZİZ SERKAN and UZUN, ORHAN and DİNCER, MURSİT and HAVAN, NURİ and POLAT, ERDAL and DUMAN, MUSTAFA},
  title = {Delta lactate-to-albumin ratio predicts major complications in patients with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy ​},
  journal = {Turkish Journal of Medical Sciences},
  year = {2026},
  volume = {56},
  number = {5},
  pages = {1556--1564},
  doi = {10.55730/1300-0144.6401}
}
Kostenlos starten →